Insider Transactions in Q3 2023 at An2 Therapeutics, Inc. (ANTX)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 29
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
99,101
-3.84%
|
$1,585,616
$16.28 P/Share
|
Sep 29
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
15,764
-3.84%
|
$252,224
$16.28 P/Share
|
Sep 29
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
83,337
-3.84%
|
$1,333,392
$16.28 P/Share
|
Sep 28
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
8,516
-0.33%
|
$136,256
$16.11 P/Share
|
Sep 28
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
1,356
-0.33%
|
$21,696
$16.11 P/Share
|
Sep 28
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
7,160
-0.33%
|
$114,560
$16.11 P/Share
|
Sep 27
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
841
-0.03%
|
$13,456
$16.07 P/Share
|
Sep 27
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
134
-0.03%
|
$2,144
$16.07 P/Share
|
Sep 27
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
707
-0.03%
|
$11,312
$16.07 P/Share
|
Sep 13
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
400
-0.02%
|
$6,400
$16.0 P/Share
|
Sep 13
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
64
-0.02%
|
$1,024
$16.0 P/Share
|
Sep 13
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
336
-0.02%
|
$5,376
$16.0 P/Share
|
Sep 07
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
537
-0.13%
|
$8,592
$16.05 P/Share
|
Sep 07
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
2,841
-0.13%
|
$45,456
$16.05 P/Share
|
Sep 07
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
3,378
-0.13%
|
$54,048
$16.05 P/Share
|
Sep 06
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
598
-0.14%
|
$9,568
$16.02 P/Share
|
Sep 06
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
3,164
-0.14%
|
$50,624
$16.02 P/Share
|
Sep 06
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
3,762
-0.14%
|
$60,192
$16.02 P/Share
|
Aug 23
2023
|
Kabeer Aziz |
SELL
Open market or private sale
|
Indirect |
400
-0.02%
|
$6,400
$16.0 P/Share
|
Aug 23
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Indirect |
64
-0.02%
|
$1,024
$16.0 P/Share
|
Aug 23
2023
|
Adjuvant Global Health Technology Fund, L.P. |
SELL
Open market or private sale
|
Direct |
336
-0.02%
|
$5,376
$16.0 P/Share
|
Aug 18
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,777,778
+25.71%
|
$16,000,002
$9.0 P/Share
|